Covington Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$932K Buy
2,052
+104
+5% +$49.8K 0.04% 230
2022
Q2
$940K Buy
1,948
+6
+0.3% +$2.97K 0.04% 233
2022
Q1
$954K Hold
1,942
0.03% 236
2021
Q4
$900K Sell
1,942
-25
-1% -$10.5K 0.03% 233
2021
Q3
$733K Sell
1,967
-14
-0.7% -$5.32K 0.03% 247
2021
Q2
$756K Buy
1,981
+250
+14% +$95.5K 0.03% 244
2021
Q1
$621K Buy
1,731
+4
+0.2% +$1.29K 0.03% 252
2020
Q4
$555K Hold
1,727
0.03% 251
2020
Q3
$464K Sell
1,727
-266
-13% -$71.6K 0.02% 255
2020
Q2
$524K Sell
1,993
-237
-11% -$63.2K 0.03% 235
2020
Q1
$506K Buy
2,230
+2,174
+3,882% +$592K 0.03% 220
2019
Q4
$17K Hold
56
﹤0.01% 621
2019
Q3
$13K Buy
56
+29
+107% +$7.95K ﹤0.01% 618
2019
Q2
$8K Buy
+27
New +$7.38K ﹤0.01% 658

Other funds holding ELV

Covington Capital Management's ELV Position: Q3 2022 in Review

Covington Capital Management increased its Elevance Health (ELV) stake by 5.3% in Q3 2022, buying an estimated $49.8K and bringing the position to 2,052 shares worth $932K. The position accounts for 0.04% of the portfolio, ranked #230.

Covington Capital Management first reported a position in ELV in Q2 2019 and has held it in 14 quarters since. The position peaked at $954K in Q1 2022. 1,446 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • Covington Capital Management held 2,052 shares of Elevance Health worth $932K as of Q3 2022.
  • Covington Capital Management bought 104 Elevance Health shares in Q3 2022, an estimated $49.8K.
  • Elevance Health made up 0.04% of Covington Capital Management's portfolio in Q3 2022, its #230 holding.
  • Covington Capital Management first reported a position in Elevance Health in Q2 2019 and has held it in 14 quarters since.
  • Covington Capital Management's Elevance Health position peaked at $954K in Q1 2022.
  • 1,446 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.